
SOSV
Description
SOSV is a prominent deep tech venture capital firm headquartered in Princeton, United States, renowned for its unique accelerator model that invests from a startup's inception. With over $1.5 billion in assets under management, SOSV has established itself as a significant player in the early-stage venture ecosystem, particularly for companies tackling complex scientific and engineering challenges. The firm's strategy is centered around its highly specialized accelerator programs, which provide intensive support, mentorship, and capital to nascent companies in specific sectors.
The core of SOSV's investment approach lies in its flagship programs: HAX, focusing on hard tech and industrial innovation, and IndieBio, dedicated to life sciences and biotech. Through these accelerators, SOSV typically provides an initial investment ranging from $250,000 to $500,000 in exchange for equity, coupled with hands-on operational support and access to state-of-the-art lab and workshop facilities. This structured, program-driven investment model allows SOSV to de-risk early-stage deep tech ventures and prepare them for subsequent funding rounds. Their commitment extends beyond the initial cheque, as they actively participate in follow-on rounds for their most promising portfolio companies.
Since its inception, SOSV has built an extensive portfolio, having invested in over 1,000 companies across various deep tech domains, including climate tech, food tech, and advanced manufacturing. This vast network and strategic follow-on support have enabled their portfolio companies to collectively raise over $11 billion in additional capital from external investors. SOSV's distinctive model, combining early-stage capital with intensive operational mentorship, positions it as a critical partner for founders building breakthrough technologies with significant global impact.
Investor Profile
SOSV has backed more than 2,703 startups, with 121 new investments in the last 12 months alone. The firm has led 1,063 rounds, about 39% of its total and boasts 76 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Convertible Note, Pre Seed rounds (top funding stages).
- Majority of deals are located in United States, China, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Led 37 rounds in the past year.
- Typical check size: $250K – $1M.
Stage Focus
- Seed (50%)
- Convertible Note (23%)
- Pre Seed (13%)
- Series A (6%)
- Series Unknown (4%)
- Series B (2%)
- Series C (1%)
- Angel (1%)
Country Focus
- United States (49%)
- China (7%)
- United Kingdom (6%)
- Canada (6%)
- Ireland (4%)
- India (3%)
- Singapore (3%)
- Hong Kong (2%)
- Germany (2%)
- France (1%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Food And Beverage
- Artificial Intelligence (Ai)
- Medical
- Information Technology
- Manufacturing
- Hardware
- E-commerce
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.